12/18
09:09 am
imvt
Immunovant (NASDAQ:IMVT) had its "buy" rating reaffirmed by analysts at Guggenheim.
Medium
Report
Immunovant (NASDAQ:IMVT) had its "buy" rating reaffirmed by analysts at Guggenheim.
12/18
09:09 am
imvt
Immunovant (NASDAQ:IMVT) had its "buy" rating reaffirmed by analysts at Guggenheim.
Medium
Report
Immunovant (NASDAQ:IMVT) had its "buy" rating reaffirmed by analysts at Guggenheim.
12/15
12:47 pm
imvt
Rating for IMVT
Low
Report
Rating for IMVT
12/15
12:47 pm
imvt
Rating for IMVT
Low
Report
Rating for IMVT
12/15
12:47 pm
imvt
Rating for IMVT
Low
Report
Rating for IMVT
9/30
08:28 am
imvt
Rating for IMVT
Low
Report
Rating for IMVT